Nuvation Bio Inc.
NYSE:NUVB
2.1 (USD) • At close May 8, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|
| Revenue
| 7.873 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 7.078 | 0.222 | 0.484 | 0.368 | 0.103 | 0 | 0 |
| Gross Profit
| 0.795 | -0.222 | -0.484 | -0.368 | -0.103 | 0 | 0 |
| Gross Profit Ratio
| 0.101 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 99.119 | 71.289 | 87.815 | 69.037 | 32.603 | 25.106 | 0.483 |
| General & Administrative Expenses
| 0 | 26.833 | 31.919 | 24.281 | 10.948 | 6.593 | 0.509 |
| Selling & Marketing Expenses
| 0 | 1.7 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 69.233 | 28.533 | 31.919 | 24.281 | 10.948 | 6.993 | 0.509 |
| Other Expenses
| 425.07 | 0 | -0.872 | -0.644 | -0.271 | 0 | 0 |
| Operating Expenses
| 586.344 | 99.822 | 119.734 | 93.318 | 43.551 | 32.181 | 0.992 |
| Operating Income
| -592.627 | -99.822 | -119.734 | -93.318 | -43.551 | -32.099 | -0.992 |
| Operating Income Ratio
| -75.273 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 24.688 | 24.02 | 15.535 | 6.47 | 1.892 | -1.453 | 0 |
| Income Before Tax
| -567.939 | -75.802 | -104.199 | -86.848 | -41.659 | -33.552 | -0.992 |
| Income Before Tax Ratio
| -72.138 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0 | 0 | -15.535 | -7.114 | -2.163 | 0 | 0 |
| Net Income
| -567.939 | -75.802 | -88.664 | -79.734 | -39.496 | -33.552 | -0.992 |
| Net Income Ratio
| -72.138 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -2.11 | -0.35 | -0.41 | -0.4 | -0.4 | -0.16 | -0.012 |
| EPS Diluted
| -2.11 | -0.35 | -0.41 | -0.4 | -0.4 | -0.16 | -0.012 |
| EBITDA
| -566.915 | -99.6 | -119.535 | -89.347 | -43.448 | -32.086 | 0 |
| EBITDA Ratio
| -72.007 | 0 | 0 | 0 | 0 | 0 | 0 |